Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic
cell transplantation (HCT) and is associated with significant morbidity and mortality. For …

Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …

Chronic graft-versus-host disease (cGVHD) is a major immunologic complication of
allogeneic hematopoietic cell transplantation. cGVHD involves multiple organs, reduces …

Pulmonary chronic graft-versus-host disease (cGVHD) is a substantial cause of pulmonary
morbidity and mortality post-haematopoietic stem cell transplantation (HSCT). Current …

Historically, the eye has been considered as an organ free of lymphatic vessels. In recent
years, however, it became evident, that lymphatic vessels or lymphatic-like vessels …

Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …

Simple Summary Dysregulated microRNA (miRNA) expression has been described in the
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …

Purpose To validate the international chronic ocular graft-versus-host disease (GVHD)
diagnostic criteria (ICCGVHD) compared to the National Institute of Health diagnostic criteria …

BACKGROUND Chronic graft-versus-host disease (cGVHD) is a serious complication of
allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding …

Hematopoietic cell transplantation (HCT) is a potentially curative treatment for many
hematologic and nonhematologic disorders. Graft-versus-host-disease (GVHD) in its acute …